Artasan specializes in sales and marketing of pharmaceuticals, medical devices and healthcare products.
- Artasan works in partnership with several of the largest OTC and generic pharmaceutical manufacturers in the world, as well as renowned healthcare product manufacturers. Artasan provides them with services relating to import, registration, distribution and sales & marketing.
Artasan distributes to pharmacies, health food stores, convenience stores, petrol stations, dentists, hospitals and nursing homes. - The emphasis is on high-quality products, and each brand that the company represents enjoys a strong position with consumers. Marketing strategies are developed in close collaboration with manufacturers and each supplier receives exclusive attention.
- The company focuses on servicing its customers in the best possible way with efficient and targeted activities, constantly looking at ways of improving. In this way, we want to create a working environment that attracts qualified employees and enables our partners to reach their goals. This is done for the benefit of our customers, consumers, employees and owners.
Artasan aims to be the preferred partner in the Icelandic market for pharmaceuticals and healthcare products, as well as in the minds of customers, suppliers, employees and the community.
What we can do for your company
- Whether it is providing a sales force or marketing expertise, or taking care of imports, logistics and distribution, Artasan is the partner of choice for a range of companies that want to enter and increase their market share in the Icelandic market.
Our value proposition lies in providing expert knowledge of the local market conditions and excellent relations with customers in various segments, as well as providing specialized knowledge of regulatory affairs, and good relations with the authorities.
-
Our business model offers an effective and supportive infrastructure, rigid financial management and control measures and a partnership with our sister company Distica, a first class distribution company with a ISO9001 and GDP certified distribution and warehousing system.
Finally, and perhaps most importantly, we offer our partners a solid business relationship, where confidentiality and trust are paramount.
-
- Expert knowledge of the local market
- One stop shop for marketing and distribution in Iceland
- Go to market
- New product launces
- Brand building
- Category Management
- Key Account Management
-
- Designated sales representatives
- Excellent relations and access to customers in various segments
- Access to Key Opinion Leaders and influencers
- Providing specialized knowledge of regulatory affairs and good relations with the authorities
- Rigid financial management and control measures
- Inventory management
Organization chart

Brynjúlfur Guðmundsson
General Manager


-
Sales
Þórhallur Baldursson
Sales Manager
-
Consumer Goods
Bryndís Ragna Hákonardóttir
Marketing Manager
-
OTC
Arnþór Jóhannsson
Marketing Manager
-
Generics 1
Hildur Þórðardóttir
Marketing Manager
-
Generics 2
Helga Þóra Eiríksdóttir
Marketing Manager
Management

Brynjulfur Gudmundsson
General Manager
Prior to taking on the position of Artasan’s General Manager, Mr. Gudmundsson was Marketing Manager of OTC medicine at Artasan. He has previously worked as a consultant at Accenture in London, England and as a Marketing Representative for Europe and Asia at ARRI in London, England.
Mr. Gudmundsson holds an MBA degree and a BSc in international marketing from Reykjavik University.
Board of Directors

Hrund Rudolfsdottir
Chairman of the board
Mrs. Hrund Rudolfsdottir is the CEO of Veritas as from October 15, 2013. She succeeded Mr. Hreggvidur Jonsson, the main shareholder of Veritas, who had been the CEO of Veritas since 2002. Previously Mrs. Rudolfsdottir was Corporate Director of Human Resources at Marel Food Systems Corporate. She has held various leadership positions in the past, including Director of operation and investments at Moderna Finance ehf./Milestone ehf., CEO for L&H Holding (part of the Milestone group) responsible for all its investments within the health, retail and pharmaceutical sector, both in Iceland as well as abroad, CEO for Lyf & heilsa hf. (the second largest chain of pharmacies in Iceland) and Chief of Operation at Lyf & heilsa hf. Mrs. Rudolfsdottir also serves on the boards of various companies and committees, both in Iceland and abroad. She holds a Master of Science degree from Copenhagen Business School, a Cand.Oecon. degree, with Management as a major degree, from the University of Iceland, as well as having finished an Advanced Management Program (AMP) at IESE Business School.

Magnus Norddahl
He has over 25 years’ experience in various management positions within industries such as Software Development, IT, Pharmaceutical and Banking in Iceland, Europe and in the United States. He has a proven track record and management skills, focusing on customer relations, quality, sustainability, profitability and controlled growth. Magnus graduated with a B.Sc. in Computer Science and Mathematics from Rockford College in 1986, with an B.Sc. in Electrical Engineering in 1988 and a M.Sc. in Electrical Engineering in 1989 from the University of California.

Fjolvar Darri Rafnsson
Mr. Fjolvar Darri Rafnsson is the General Manger of Arro Investments ehf and the Chairman of Magna verslana ehf. Previously, Mr. Rafnson was the CFO of Moberg ehf from 2012-2016. He was the CEO and owner of Skifan Ltd from 2010-2012. From the year 2006 to 2010 he was CEO of Pharma Investment B.V., which was owned by Milestone and EBRD, which was focused on pharmaceutical investments in Eastern Europe. Before that he was assistant CEO of Dagur Group and CEO of Office1, 2004-2006. Mr. Rafnsson served as a Human Resource Director and Operational Manager at Lyfja during the years 2000-2004 and from 1999-2000 he worked at Capacent Iceland. Mr. Rafnsson also serves on the boards of various Icelandic companies. He holds a Bachelor's degree in Psychology from the University of Iceland.
Corporate Values
These values serve as guiding light for our employees in their daily work.
Reliability means keeping promises and having integrity, professionalism and honesty as a guiding light. Our partners, suppliers, customers and community can trust what we say and promise and may rest assured that we obey laws and regulations that apply to our business.
.
Candor creates the foundation for an honest work environment. We give clear messages and say what´s on our mind in a tactful and constructive way. We want to activate as many opinions as possible and stimulate critical thinking. Getting straight to the point saves time.
Progress represents employees’ desire and endeavors to grow, develop and improve. We constantly strive to do better – a final solution does not exist. We are open to changes and innovation, we show initiative and challenge the present situation.
Corporate Governance
Veritas emphasizes transparency, integrity and morality in its business. It honors the values of the Company and its subsidiaries; Reliability, Candor and Progress.
The Company conforms to Guidelines on Corporate Governance published by the Iceland Chamber of Commerce et al. This includes guidelines on the adoption of rules that go a step further than required by the law and are intended to strengthen the Company’s infrastructure and the the community’s trust towards it.
Disclosure code
The EFPIA Disclosure Code came effectively into force January 1, 2015. A collective decision has been taken that all disclosures are to be made the same day, June 30th 2016. Vistor is co-operating with Frumtök (the Icelandic Association of the Pharmaceutical Industry). Although Frumtök is not a formal member of EFPIA it acknowledges the Disclosure Code and fully implements it, as it has done with the EFPIA HCP code. This decision has been approved by Frumtök‘s board and discussed at Frumtök‘s members meeting with no objections.
In January 2013 the Federation of Trade and Services and the Icelandic Federation of Trade joint with Frumtök and signed an agreement with the Icelandic Medical Association, formally agreeing that the HCP code with future additions + local appendixes shall be the foundation of its interactions. What is especially positive is the fact that the Federation of Trade and Services and the Icelandic Federation of Trade signed it on behalf of their member companies, including Vistor, and consequently applicable to all MAHs serviced by these companies in Iceland. In fact, this means the whole pharma industry in Iceland has signed to use the EPFIA codes as a foundation for its interactions with health care professionals.
Each company will make its own decisions regarding its disclosures, but Frumtök has been in talks with both the Doctors Association and the National Hospital and there is a common agreement that Frumtök, plus the spokespersons for the two other bodies, will answer publicly for all matters related to the Disclosure Code.
Veritas
Veritas is the parent company to several companies that provide supplies and services to the healthcare sector in Iceland. The group consists of operating companies focusing on their core competencies to service selected segments of the healthcare market.
The role of the parent company is to handle all support services for its subsidiaries, such as financial management, IT services, human resource services, and marketing support.
The leading sales and marketing company for R&D pharmaceuticals in Iceland, Vistor provides all local services ranging from marketing, regulatory affairs and clinical operations to distribution services.
A specialized company in logistics, warehousing and distribution of pharmaceuticals, healthcare products, medical products and other products for the healthcare sector and laboratories in Iceland, with almost 60 years’ experience.
MEDOR is a leading medical device and laboratory products distributor in Iceland.
Recognitions
-
Equal Pay PWC
-
Artasan was voted one of 5 best companies to work for in Iceland in a yearly nation-wide employee survey managed by VR, the commercial and office workers ‘union.
-
Strongest in Iceland 2016-2020
Corporate social responsibility